New projects will lead to improved diagnosis, reduced side effects of existing treatments, and the development of new, more effective ones
13 March, 2017
The neuroscience digital health company Cambridge Cognition Holdings PLC, which develops and markets software products to improve brain health worldwide, today announced the launch of a new web-based testing product for conducting academic and clinical research studies online. Disorders affecting the brain are now the leading cause of disability and ill health worldwide. More than 1,000 disorders of the brain and central nervous system (CNS) result in huge costs and more hospitalisations and lost productivity than any other disease group, including heart disease and cancer.
07 March, 2017